|
Leader
|
|
|
00000nz a2200037n 45 0 |
|
001
|
|
|
WKP|Q59087670
(VIAF cluster)
(Authority/Source Record)
|
|
003
|
|
|
WKP |
|
005
|
|
|
20241221010725.0 |
|
008
|
|
|
241221nneanz||abbn n and d |
|
035
|
|
|
‡a
(WKP)Q59087670
|
|
024
|
|
|
‡a
0000-0002-1498-048X
‡2
orcid
|
|
024
|
|
|
‡a
7003744166
‡2
scopus
|
|
035
|
|
|
‡a
(OCoLC)Q59087670
|
|
100
|
0 |
|
‡a
Isabel F Almeida
‡c
researcher ORCID ID = 0000-0002-1498-048X
‡9
en
|
|
375
|
|
|
‡a
2
‡2
iso5218
|
|
400
|
0 |
|
‡a
Isabel F Almeida
‡c
wetenschapper
‡9
nl
|
|
670
|
|
|
‡a
Author's Added-Value Compounds in Cork By-Products: Methods for Extraction, Identification, and Quantification of Compounds with Pharmaceutical and Cosmetic Interest
|
|
670
|
|
|
‡a
Author's Addressing the digital divide: who is being left behind in the evaluation of e-Health interventions to improve medication adherence?
|
|
670
|
|
|
‡a
Author's Alginate microparticles as carriers for the UV filter 2-ethylhexyl 4-methoxycinnamate: Influence on photostability
|
|
670
|
|
|
‡a
Author's An Overview of Proprietary Vehicles/Bases for Topical Compounding Medicines and Cosmetics
|
|
670
|
|
|
‡a
Author's Anti-inflammatory and antioxidant nanostructured cellulose membranes loaded with phenolic-based ionic liquids for cutaneous application
|
|
670
|
|
|
‡a
Author's Application of NIR Spectroscopy for the Valorisation of Cork By-Products: A Feasibility Study over the Screening and Discrimination of Chemical Compounds of Interest
|
|
670
|
|
|
‡a
Author's Bacterial cellulose membranes applied in topical and transdermal delivery of lidocaine hydrochloride and ibuprofen: in vitro diffusion studies.
|
|
670
|
|
|
‡a
Author's Bacterial cellulose membranes as transdermal delivery systems for diclofenac: In vitro dissolution and permeation studies
|
|
670
|
|
|
‡a
Author's Biocellulose membranes as supports for dermal release of lidocaine
|
|
670
|
|
|
‡a
Author's Characterization of an antioxidant surfactant-free topical formulation containing Castanea sativa leaf extract
|
|
670
|
|
|
‡a
Author's Characterization of Liquid Dosage Forms of Atenolol and Enalapril Maleate for Oral and Enteral Feeding Administration
|
|
670
|
|
|
‡a
Author's Comparative Studies on the Photoreactivity, Efficacy, and Safety of Depigmenting Agents
|
|
670
|
|
|
‡a
Author's Development and Validation of a Novel Questionnaire for Adherence with Topical Treatments in Psoriasis
|
|
670
|
|
|
‡a
Author's Development and Validation of a Novel Questionnaire for Adherence with Topical Treatments in Psoriasis (QATOP).
|
|
670
|
|
|
‡a
Author's Efficacy, Stability, and Safety Evaluation of New Polyphenolic Xanthones Towards Identification of Bioactive Compounds to Fight Skin Photoaging
|
|
670
|
|
|
‡a
Author's Evaluation of functional stability and batch-to-batch reproducibility of a Castanea sativa leaf extract with antioxidant activity.
|
|
670
|
|
|
‡a
Author's Evaluation of the physical stability of two oleogels
|
|
670
|
|
|
‡a
Author's Evolution of the use of antioxidants in anti-ageing cosmetics
|
|
670
|
|
|
‡a
Author's Implementation of an in vitro methodology for phototoxicity evaluation in a human keratinocyte cell line
|
|
670
|
|
|
‡a
Author's In vitro cytotoxicity evaluation of resveratrol-loaded nanoparticles: Focus on the challenges of in vitro methodologies
|
|
670
|
|
|
‡a
Author's In vitro protective effect of Hypericum androsaemum extract against oxygen and nitrogen reactive species.
|
|
670
|
|
|
‡a
Author's In vivo skin irritation potential of a Castanea sativa (Chestnut) leaf extract, a putative natural antioxidant for topical application.
|
|
670
|
|
|
‡a
Author's Influence of Clinical and Psychosocial Factors on the Adherence to Topical Treatment in Psoriasis
|
|
670
|
|
|
‡a
Author's Influence of lipid microparticle encapsulation on in vitro efficacy, photostability and water resistance of the sunscreen agents, octyl methoxycinnamate and butyl methoxydibenzoylmethane
|
|
670
|
|
|
‡a
Author's Injectability of a bone filler system based on hydroxyapatite microspheres and a vehicle with in situ gel-forming ability.
|
|
670
|
|
|
‡a
Author's Moisturizing Effect of Oleogel/Hydrogel Mixtures
|
|
670
|
|
|
‡a
Author's Overcoming Challenges in Pediatric Formulation with a Patient-Centric Design Approach: A Proof-of-Concept Study on the Design of an Oral Solution of a Bitter Drug
|
|
670
|
|
|
‡a
Author's Oxygen and nitrogen reactive species are effectively scavenged by Eucalyptus globulus leaf water extract.
|
|
670
|
|
|
‡a
Author's Patient-Centric Design of Topical Dermatological Medicines
|
|
670
|
|
|
‡a
Author's Patient Centric Pharmaceutical Drug Product Design-The Impact on Medication Adherence
|
|
670
|
|
|
‡a
Author's Photodegradation of avobenzone: stabilization effect of antioxidants.
|
|
670
|
|
|
‡a
Author's Photostabilization Strategies of Photosensitive Drugs
|
|
670
|
|
|
‡a
Author's Potential benefits of a sulfated resveratrol derivative for topical application.
|
|
670
|
|
|
‡a
Author's Protective effect of C. sativa leaf extract against UV mediated-DNA damage in a human keratinocyte cell line.
|
|
670
|
|
|
‡a
Author's Protective effect of Castanea sativa and Quercus robur leaf extracts against oxygen and nitrogen reactive species
|
|
670
|
|
|
‡a
Author's Quercus suber: A Promising Sustainable Raw Material for Cosmetic Application
|
|
670
|
|
|
‡a
Author's Strontium-rich injectable hybrid system for bone regeneration
|
|
670
|
|
|
‡a
Author's The Mediator Role of Body Image-Related Cognitive Fusion in the Relationship between Disease Severity Perception, Acceptance and Psoriasis Disability
|
|
909
|
|
|
‡a
(scopus) 7003744166
‡9
1
|
|
909
|
|
|
‡a
(orcid) 000000021498048x
‡9
1
|
|
919
|
|
|
‡a
protectiveeffectofcastaneasativaandquercusroburleafextractsagainstoxygenandnitrogenreactivespecies
‡A
Protective effect of Castanea sativa and Quercus robur leaf extracts against oxygen and nitrogen reactive species
‡9
1
|
|
919
|
|
|
‡a
protectiveeffectof100sativaleafextractagainstuvmediateddnadamageinahumankeratinocytecellline
‡A
Protective effect of C. sativa leaf extract against UV mediated-DNA damage in a human keratinocyte cell line.
‡9
1
|
|
919
|
|
|
‡a
potentialbenefitsofasulfatedresveratrolderivativefortopicalapplication
‡A
Potential benefits of a sulfated resveratrol derivative for topical application.
‡9
1
|
|
919
|
|
|
‡a
photostabilizationstrategiesofphotosensitivedrugs
‡A
Photostabilization Strategies of Photosensitive Drugs
‡9
1
|
|
919
|
|
|
‡a
photodegradationofavobenzonestabilizationeffectofantioxidants
‡A
Photodegradation of avobenzone: stabilization effect of antioxidants.
‡9
1
|
|
919
|
|
|
‡a
patientcentricpharmaceuticaldrugproductdesigntheimpactonmedicationadherence
‡A
Patient Centric Pharmaceutical Drug Product Design-The Impact on Medication Adherence
‡9
1
|
|
919
|
|
|
‡a
patientcentricdesignoftopicaldermatologicalmedicines
‡A
Patient-Centric Design of Topical Dermatological Medicines
‡9
1
|
|
919
|
|
|
‡a
oxygenandnitrogenreactivespeciesareeffectivelyscavengedbyeucalyptusglobulusleafwaterextract
‡A
Oxygen and nitrogen reactive species are effectively scavenged by Eucalyptus globulus leaf water extract.
‡9
1
|
|
919
|
|
|
‡a
overcomingchallengesinpediatricformulationwithapatientcentricdesignapproachaproofofconceptstudyonthedesignofanoralsolutionofabitterdrug
‡A
Overcoming Challenges in Pediatric Formulation with a Patient-Centric Design Approach: A Proof-of-Concept Study on the Design of an Oral Solution of a Bitter Drug
‡9
1
|
|
919
|
|
|
‡a
moisturizingeffectofoleogelhydrogelmixtures
‡A
Moisturizing Effect of Oleogel/Hydrogel Mixtures
‡9
1
|
|
919
|
|
|
‡a
injectabilityofabonefillersystembasedonhydroxyapatitemicrospheresandavehiclewithinsitugelformingability
‡A
Injectability of a bone filler system based on hydroxyapatite microspheres and a vehicle with in situ gel-forming ability.
‡9
1
|
|
919
|
|
|
‡a
influenceoflipidmicroparticleencapsulationoninvitroefficacyphotostabilityandwaterresistanceofthesunscreenagentsoctylmethoxycinnamateandbutylmethoxydibenzoylmethane
‡A
Influence of lipid microparticle encapsulation on in vitro efficacy, photostability and water resistance of the sunscreen agents, octyl methoxycinnamate and butyl methoxydibenzoylmethane
‡9
1
|
|
919
|
|
|
‡a
influenceofclinicalandpsychosocialfactorsontheadherencetotopicaltreatmentinpsoriasis
‡A
Influence of Clinical and Psychosocial Factors on the Adherence to Topical Treatment in Psoriasis
‡9
1
|
|
919
|
|
|
‡a
invivoskinirritationpotentialofacastaneasativachestnutleafextractaputativenaturalantioxidantfortopicalapplication
‡A
In vivo skin irritation potential of a Castanea sativa (Chestnut) leaf extract, a putative natural antioxidant for topical application.
‡9
1
|
|
919
|
|
|
‡a
invitroprotectiveeffectofhypericumandrosaemumextractagainstoxygenandnitrogenreactivespecies
‡A
In vitro protective effect of Hypericum androsaemum extract against oxygen and nitrogen reactive species.
‡9
1
|
|
919
|
|
|
‡a
invitrocytotoxicityevaluationofresveratrolloadednanoparticlesfocusonthechallengesofinvitromethodologies
‡A
In vitro cytotoxicity evaluation of resveratrol-loaded nanoparticles: Focus on the challenges of in vitro methodologies
‡9
1
|
|
919
|
|
|
‡a
implementationofaninvitromethodologyforphototoxicityevaluationinahumankeratinocytecellline
‡A
Implementation of an in vitro methodology for phototoxicity evaluation in a human keratinocyte cell line
‡9
1
|
|
919
|
|
|
‡a
evolutionoftheuseofantioxidantsinantiageingcosmetics
‡A
Evolution of the use of antioxidants in anti-ageing cosmetics
‡9
1
|
|
919
|
|
|
‡a
evaluationofthephysicalstabilityof2oleogels
‡A
Evaluation of the physical stability of two oleogels
‡9
1
|
|
919
|
|
|
‡a
evaluationoffunctionalstabilityandbatchtobatchreproducibilityofacastaneasativaleafextractwithantioxidantactivity
‡A
Evaluation of functional stability and batch-to-batch reproducibility of a Castanea sativa leaf extract with antioxidant activity.
‡9
1
|
|
919
|
|
|
‡a
efficacystabilityandsafetyevaluationofnewpolyphenolicxanthonestowardsidentificationofbioactivecompoundstofightskinphotoaging
‡A
Efficacy, Stability, and Safety Evaluation of New Polyphenolic Xanthones Towards Identification of Bioactive Compounds to Fight Skin Photoaging
‡9
1
|
|
919
|
|
|
‡a
developmentandvalidationofanovelquestionnaireforadherencewithtopicaltreatmentsinpsoriasisqatop
‡A
Development and Validation of a Novel Questionnaire for Adherence with Topical Treatments in Psoriasis (QATOP).
‡9
1
|
|
919
|
|
|
‡a
developmentandvalidationofanovelquestionnaireforadherencewithtopicaltreatmentsinpsoriasis
‡A
Development and Validation of a Novel Questionnaire for Adherence with Topical Treatments in Psoriasis
‡9
1
|
|
919
|
|
|
‡a
comparativestudiesonthephotoreactivityefficacyandsafetyofdepigmentingagents
‡A
Comparative Studies on the Photoreactivity, Efficacy, and Safety of Depigmenting Agents
‡9
1
|
|
919
|
|
|
‡a
characterizationofliquiddosageformsofatenololandenalaprilmaleatefororalandenteralfeedingadministration
‡A
Characterization of Liquid Dosage Forms of Atenolol and Enalapril Maleate for Oral and Enteral Feeding Administration
‡9
1
|
|
919
|
|
|
‡a
characterizationofanantioxidantsurfactantfreetopicalformulationcontainingcastaneasativaleafextract
‡A
Characterization of an antioxidant surfactant-free topical formulation containing Castanea sativa leaf extract
‡9
1
|
|
919
|
|
|
‡a
biocellulosemembranesassupportsfordermalreleaseoflidocaine
‡A
Biocellulose membranes as supports for dermal release of lidocaine
‡9
1
|
|
919
|
|
|
‡a
bacterialcellulosemembranesastransdermaldeliverysystemsfordiclofenacinvitrodissolutionandpermeationstudies
‡A
Bacterial cellulose membranes as transdermal delivery systems for diclofenac: In vitro dissolution and permeation studies
‡9
1
|
|
919
|
|
|
‡a
bacterialcellulosemembranesappliedintopicalandtransdermaldeliveryoflidocainehydrochlorideandibuprofeninvitrodiffusionstudies
‡A
Bacterial cellulose membranes applied in topical and transdermal delivery of lidocaine hydrochloride and ibuprofen: in vitro diffusion studies.
‡9
1
|
|
919
|
|
|
‡a
applicationofnirspectroscopyforthevalorisationofcorkbyproductsafeasibilitystudyoverthescreeninganddiscriminationofchemicalcompoundsofinterest
‡A
Application of NIR Spectroscopy for the Valorisation of Cork By-Products: A Feasibility Study over the Screening and Discrimination of Chemical Compounds of Interest
‡9
1
|
|
919
|
|
|
‡a
antiinflammatoryandantioxidantnanostructuredcellulosemembranesloadedwithphenolicbasedionicliquidsforcutaneousapplication
‡A
Anti-inflammatory and antioxidant nanostructured cellulose membranes loaded with phenolic-based ionic liquids for cutaneous application
‡9
1
|
|
919
|
|
|
‡a
overviewofproprietaryvehiclesbasesfortopicalcompoundingmedicinesandcosmetics
‡A
An Overview of Proprietary Vehicles/Bases for Topical Compounding Medicines and Cosmetics
‡9
1
|
|
919
|
|
|
‡a
alginatemicroparticlesascarriersfortheuvfilter2ethylhexyl4methoxycinnamateinfluenceonphotostability
‡A
Alginate microparticles as carriers for the UV filter 2-ethylhexyl 4-methoxycinnamate: Influence on photostability
‡9
1
|
|
919
|
|
|
‡a
addressingthedigitaldividewhoisbeingleftbehindintheevaluationofehealthinterventionstoimprovemedicationadherence
‡A
Addressing the digital divide: who is being left behind in the evaluation of e-Health interventions to improve medication adherence?
‡9
1
|
|
919
|
|
|
‡a
addedvaluecompoundsincorkbyproductsmethodsforextractionidentificationandquantificationofcompoundswithpharmaceuticalandcosmeticinterest
‡A
Added-Value Compounds in Cork By-Products: Methods for Extraction, Identification, and Quantification of Compounds with Pharmaceutical and Cosmetic Interest
‡9
1
|
|
919
|
|
|
‡a
mediatorroleofbodyimagerelatedcognitivefusionintherelationshipbetweendiseaseseverityperceptionacceptanceandpsoriasisdisability
‡A
The Mediator Role of Body Image-Related Cognitive Fusion in the Relationship between Disease Severity Perception, Acceptance and Psoriasis Disability
‡9
1
|
|
919
|
|
|
‡a
strontiumrichinjectablehybridsystemforboneregeneration
‡A
Strontium-rich injectable hybrid system for bone regeneration
‡9
1
|
|
919
|
|
|
‡a
quercussuberapromisingsustainablerawmaterialforcosmeticapplication
‡A
Quercus suber: A Promising Sustainable Raw Material for Cosmetic Application
‡9
1
|
|
946
|
|
|
‡a
a
‡9
1
|
|
996
|
|
|
‡2
ISNI|000000037347471X
|
|
996
|
|
|
‡2
PTBNP|1366861
|
|
996
|
|
|
‡2
LC|n 2012212632
|
|
996
|
|
|
‡2
BLBNB|000478815
|
|
996
|
|
|
‡2
ISNI|0000000069013353
|
|
996
|
|
|
‡2
ISNI|0000000068203956
|
|
996
|
|
|
‡2
PTBNP|1457332
|
|
996
|
|
|
‡2
PTBNP|2090
|
|
996
|
|
|
‡2
BLBNB|001500271
|
|
996
|
|
|
‡2
PTBNP|2094
|
|
996
|
|
|
‡2
ISNI|0000000043169333
|
|
996
|
|
|
‡2
ISNI|0000000046060739
|
|
996
|
|
|
‡2
ISNI|0000000069392429
|
|
996
|
|
|
‡2
PTBNP|1578427
|
|
996
|
|
|
‡2
ISNI|0000000068489456
|
|
996
|
|
|
‡2
SUDOC|193213079
|
|
996
|
|
|
‡2
PTBNP|921717
|
|
996
|
|
|
‡2
LC|n 2022036161
|
|
996
|
|
|
‡2
BLBNB|001457950
|
|
996
|
|
|
‡2
SUDOC|081491514
|
|
996
|
|
|
‡2
SUDOC|158983068
|
|
996
|
|
|
‡2
SUDOC|117763586
|
|
996
|
|
|
‡2
PTBNP|1057137
|
|
996
|
|
|
‡2
LC|nb 98079449
|
|
996
|
|
|
‡2
PTBNP|1384036
|
|
996
|
|
|
‡2
ISNI|0000000070018012
|
|
996
|
|
|
‡2
PTBNP|1660144
|
|
996
|
|
|
‡2
ISNI|0000000070000058
|
|
996
|
|
|
‡2
ISNI|0000000069804040
|
|
996
|
|
|
‡2
ISNI|0000000428245392
|
|
996
|
|
|
‡2
PTBNP|44140
|
|
996
|
|
|
‡2
DNB|1056452897
|
|
996
|
|
|
‡2
ISNI|0000000068720144
|
|
996
|
|
|
‡2
PTBNP|53364
|
|
996
|
|
|
‡2
PLWABN|9810648658605606
|
|
996
|
|
|
‡2
PTBNP|1210981
|
|
996
|
|
|
‡2
ISNI|000000006981349X
|
|
996
|
|
|
‡2
PTBNP|273040
|
|
996
|
|
|
‡2
PTBNP|50950
|
|
996
|
|
|
‡2
PTBNP|1663608
|
|
996
|
|
|
‡2
PTBNP|1217449
|
|
996
|
|
|
‡2
ISNI|0000000070507828
|
|
996
|
|
|
‡2
ISNI|0000000069501867
|
|
996
|
|
|
‡2
SUDOC|277061415
|
|
996
|
|
|
‡2
ISNI|0000000382087404
|
|
996
|
|
|
‡2
PTBNP|242863
|
|
996
|
|
|
‡2
BIBSYS|90846164
|
|
996
|
|
|
‡2
NUKAT|n 2017183946
|
|
996
|
|
|
‡2
BLBNB|000505213
|
|
996
|
|
|
‡2
PTBNP|213658
|
|
996
|
|
|
‡2
J9U|987007355518005171
|
|
996
|
|
|
‡2
BLBNB|000171607
|
|
996
|
|
|
‡2
PTBNP|1609
|
|
996
|
|
|
‡2
ISNI|0000000069298723
|
|
996
|
|
|
‡2
LC|n 2012059803
|
|
996
|
|
|
‡2
DNB|1060758970
|
|
996
|
|
|
‡2
PTBNP|1055259
|
|
996
|
|
|
‡2
PTBNP|1261348
|
|
996
|
|
|
‡2
ISNI|0000000069992109
|
|
996
|
|
|
‡2
ISNI|0000000068903952
|
|
996
|
|
|
‡2
SUDOC|17110160X
|
|
996
|
|
|
‡2
ISNI|0000000068815901
|
|
996
|
|
|
‡2
SUDOC|077661141
|
|
996
|
|
|
‡2
PTBNP|1291963
|
|
996
|
|
|
‡2
DNB|1060759381
|
|
996
|
|
|
‡2
LC|no2002037411
|
|
996
|
|
|
‡2
PTBNP|1708562
|
|
996
|
|
|
‡2
LC|no 91011850
|
|
996
|
|
|
‡2
BLBNB|001478426
|
|
996
|
|
|
‡2
PTBNP|1698609
|
|
996
|
|
|
‡2
DNB|136854206
|
|
996
|
|
|
‡2
ISNI|0000000068073661
|
|
996
|
|
|
‡2
PLWABN|9810651654105606
|
|
996
|
|
|
‡2
PTBNP|1319145
|
|
996
|
|
|
‡2
LC|no2012033987
|
|
996
|
|
|
‡2
PTBNP|1472709
|
|
996
|
|
|
‡2
PTBNP|1617201
|
|
996
|
|
|
‡2
PTBNP|1358264
|
|
996
|
|
|
‡2
BLBNB|001442595
|
|
996
|
|
|
‡2
LC|no2012140082
|
|
996
|
|
|
‡2
BNF|16168273
|
|
996
|
|
|
‡2
SUDOC|164511989
|
|
996
|
|
|
‡2
PTBNP|557653
|
|
996
|
|
|
‡2
ISNI|000000007328595X
|
|
996
|
|
|
‡2
PTBNP|241575
|
|
996
|
|
|
‡2
ISNI|0000000384011155
|
|
996
|
|
|
‡2
DNB|1057241156
|
|
996
|
|
|
‡2
ISNI|000000006847705X
|
|
996
|
|
|
‡2
PTBNP|1056984
|
|
996
|
|
|
‡2
DNB|1023024438
|
|
996
|
|
|
‡2
BNF|17846903
|
|
996
|
|
|
‡2
PTBNP|1704316
|
|
996
|
|
|
‡2
PTBNP|948568
|
|
996
|
|
|
‡2
PTBNP|1344808
|
|
996
|
|
|
‡2
NKC|jo20181001184
|
|
996
|
|
|
‡2
LC|no2024026840
|
|
996
|
|
|
‡2
ISNI|0000000068908163
|
|
996
|
|
|
‡2
PTBNP|1567257
|
|
996
|
|
|
‡2
PTBNP|175773
|
|
996
|
|
|
‡2
SUDOC|057022054
|
|
996
|
|
|
‡2
DNB|1089478674
|
|
996
|
|
|
‡2
BLBNB|000194996
|
|
996
|
|
|
‡2
PTBNP|206484
|
|
996
|
|
|
‡2
BNF|16690893
|
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|
